Literature DB >> 15547298

The effect of sterol regulatory element-binding protein 2 polymorphism on the serum lipid in northern Chinese subjects.

Xueying Duan1, Wenli Zhu, Yong Li, Zhentao Zhang, Yao Zhao, Jingjing Dao, Ying Xiao.   

Abstract

Sterol regulatory element-binding protein 2 (SREBP-2) is an important nuclear transcription factor in the regulation of cellular cholesterol metabolism. To determine allele frequency of the 1784G>C polymorphism at the SREBP-2 locus and investigate the relationship between this polymorphism and serum lipid levels in Chinese people, we selected 486 individuals (118 men and 368 women) from the Xicheng District of Beijing. The subjects were divided into four groups: hypercholesterolemic subjects, hypertriglyceridemic subjects, combined hyperlipidemic subjects, and normal subjects. Serum lipid profiles were measured in all subjects, and 1784G>C was analyzed using polymerase chain reaction-restriction fragment length polymorphism analysis. There was no significant difference in genotype frequencies or allele frequencies of this polymorphism between the hyperlipidemic and control groups. The serum total cholesterol (TC) and LDL cholesterol (LDL-C) levels of the individuals carrying the C allele were higher than the noncarriers in both males and females in the hypercholesterolemic group, but statistical significance was only observed in females. The results of this study indicate that the SREBP-2 polymorphism is related to elevated concentrations of serum TC and LDL-C in hypercholesterolemic subjects. Further work is necessary to confirm the role of 1784G>C in the development of hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547298     DOI: 10.1194/jlr.M400166-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Influence of SREBP-2 and SCAP gene polymorphisms on lipid-lowering response to atorvastatin in a cohort of Chilean subjects with Amerindian background.

Authors:  Jenny Lagos; Tomás Zambrano; Alexy Rosales; Luis A Salazar
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

2.  Sterol regulatory element-binding transcription factor (SREBF)-2, SREBF cleavage-activating protein (SCAP), and premature coronary artery disease in a Chinese population.

Authors:  Zhong Chen; Zhen Ding; Genshan Ma; Naifeng Liu; Qi Qian
Journal:  Mol Biol Rep       Date:  2010-01-29       Impact factor: 2.316

3.  A spontaneous mutation in Srebf2 leads to cataracts and persistent skin wounds in the lens opacity 13 (lop13) mouse.

Authors:  Kate M Merath; Bo Chang; Richard Dubielzig; Richard Jeannotte; Duska J Sidjanin
Journal:  Mamm Genome       Date:  2011-08-21       Impact factor: 2.957

4.  Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study.

Authors:  Luis M Pérez-Belmonte; Inmaculada Moreno-Santos; Fernando Cabrera-Bueno; Gemma Sánchez-Espín; Daniel Castellano; Miguel Such; María G Crespo-Leiro; Fernando Carrasco-Chinchilla; Luis Alonso-Pulpón; Miguel López-Garrido; Amalio Ruiz-Salas; Víctor M Becerra-Muñoz; Juan J Gómez-Doblas; Eduardo de Teresa-Galván; Manuel Jiménez-Navarro
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

5.  Expression of sterol regulatory element-binding transcription factor (SREBF) 2 and SREBF cleavage-activating protein (SCAP) in human atheroma and the association of their allelic variants with sudden cardiac death.

Authors:  Yue-Mei Fan; Pekka J Karhunen; Mari Levula; Erkki Ilveskoski; Jussi Mikkelsson; Olli A Kajander; Otso Järvinen; Niku Oksala; Janita Thusberg; Mauno Vihinen; Juha-Pekka Salenius; Leena Kytömäki; Juhani T Soini; Reijo Laaksonen; Terho Lehtimäki
Journal:  Thromb J       Date:  2008-12-30

6.  Association of genetic variations in the lipid regulatory pathway genes FBXW7 and SREBPs with coronary artery disease among Han Chinese and Uygur Chinese populations in Xinjiang, China.

Authors:  Asiya Abudesimu; Dilare Adi; Dilixiati Siti; Xiang Xie; Yi-Ning Yang; Xiao-Mei Li; Ying-Hong Wang; Yong-Tao Wang; Ya-Jie Meng; Fen Liu; Bang-Dang Chen; Xiang Ma; Zhen-Yan Fu; Yi-Tong Ma
Journal:  Oncotarget       Date:  2017-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.